eGenesis


egenesis health logo

Vision

eGenesis strives to create a world with no shortage of human transplantable organs.

Approach

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. eGenesis is uniquely positioned to reinvigorate the field of xenotransplantation by addressing the key virology and immunology hurdles that have impeded its advancement to date.

CEO:

Mike Curtis

Founders:

Dr. Luhan Yang

Dr. George Church

First investment:

November 2019